Log in | Register

Home
All Journals
Expert Review of Pharmacoeconomics & Outcomes Research
List of Issues
Volume 16, Issue 6

Expert Review of Pharmacoeconomics & Outcomes Research

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Review of Pharmacoeconomics & Outcomes Research, Volume 16, Issue 6 (2016)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Pharmacoeconomics & Outcomes Research, Volume 16, Issue 6 (2016)

See all volumes and issues

Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Volume 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Letter to the Editor

Letter

About the advantages and disadvantages of discrete-event simulation for health economic analyses

Mondher Toumi, Ekkehard Beck, Steve Sherman, Leyla Mohseninejad & Samuel Aballéa

Pages: 651-652

Published online: 25 Nov 2016

CitationforAbout the advantages and disadvantages of discrete-event simulation for health economic analyses | Full Text | References | PDF (194.1 KB)

149 Views
0 CrossRef citations
0Altmetric

Letter

Reply: Letter to the Editor: About the advantages and disadvantages of discrete-event simulation for health economic analyses

J. Jaime Caro & Jörgen Möller

Page: 653

Published online: 25 Nov 2016

CitationforReply: Letter to the Editor: About the advantages and disadvantages of discrete-event simulation for health economic analyses | Full Text | PDF (221.8 KB)

54 Views
0 CrossRef citations
0Altmetric

Editorial

Hepatitis C: how has France limited the expenses related to new treatments?

Anne-Laure Mouterde, François Bocquet, Isabelle Fusier & Pascal Paubel

Pages: 655-657

Published online: 27 Oct 2016

First Page PreviewforHepatitis C: how has France limited the expenses related to new treatments? | Full Text | References | PDF (332 KB)

951 Views
3 CrossRef citations
0Altmetric

Free Access

Drug Profile

Article

Patient-reported and economic outcomes related to sofosbuvir and ledipasvir treatment for chronic hepatitis C

Linda Henry & Zobair Younossi

Pages: 659-665

Published online: 12 Oct 2016

AbstractforPatient-reported and economic outcomes related to sofosbuvir and ledipasvir treatment for chronic hepatitis C | Full Text | References | PDF (571.5 KB)

188 Views
6 CrossRef citations
0Altmetric

Article

Cost-effectiveness of cetuximab for colorectal cancer

Taehwan Park, Chang-ju Choi, Yeera Choi & Dong-Churl Suh

Pages: 667-677

Published online: 20 Oct 2016

AbstractforCost-effectiveness of cetuximab for colorectal cancer | Full Text | References | PDF (852.2 KB)

459 Views
7 CrossRef citations
0Altmetric

Article

A review of the cost-effectiveness of vedolizumab for treating moderate- to severely active ulcerative colitis

Her Hsin Tsai & Christopher Black

Pages: 679-683

Published online: 24 Oct 2016

AbstractforA review of the cost-effectiveness of vedolizumab for treating moderate- to severely active ulcerative colitis | Full Text | References | PDF (377.4 KB)

504 Views
0 CrossRef citations
0Altmetric

Meeting Report

Report

Addressing challenges for sustainable healthcare in Central and Eastern Europe

Brian Godman, Tanja Novakovic, Danka Tesic, Wija Oortwijn, Antony Paul Martin, Mark Parker & Alan Haycox

Pages: 685-687

Published online: 30 Mar 2016

AbstractforAddressing challenges for sustainable healthcare in Central and Eastern Europe | Full Text | References | PDF (257.2 KB)

118 Views
4 CrossRef citations
0Altmetric

Review

How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: a five-step approach (part 1/3)

Ghislaine A.P.G. van Mastrigt, Mickaël Hiligsmann, Jacobus J.C. Arts, Pieter H. Broos, Jos Kleijnen, Silvia M.A.A. Evers & Marian H.J.M. Majoie

Pages: 689-704

Published online: 02 Nov 2016

AbstractforHow to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: a five-step approach (part 1/3) | Full Text | References | PDF (1.6 MB)

12175 Views
121 CrossRef citations
0Altmetric

Open Access

Review

How to prepare a systematic review of economic evaluations for clinical practice guidelines: database selection and search strategy development (part 2/3)

FW Thielen, GAPG Van Mastrigt, LT Burgers, WM Bramer, HJM Majoie, SMAA Evers & J Kleijnen

Pages: 705-721

Published online: 02 Nov 2016

AbstractforHow to prepare a systematic review of economic evaluations for clinical practice guidelines: database selection and search strategy development (part 2/3) | Full Text | References | PDF (1.9 MB)

11788 Views
75 CrossRef citations
0Altmetric

Open Access

Review

How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: data extraction, risk of bias, and transferability (part 3/3)

BFM Wijnen, GAPG Van Mastrigt, WK Redekop, HJM Majoie, RJA De Kinderen & SMAA Evers

Pages: 723-732

Published online: 21 Oct 2016

AbstractforHow to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: data extraction, risk of bias, and transferability (part 3/3) | Full Text | References | PDF (1,021 KB) | Supplemental

12883 Views
121 CrossRef citations
0Altmetric

Open Access

Review

Economics of ramucirumab for metastatic colorectal cancer

Simon B. Zeichner, Christine G. Kohn & Daniel A. Goldstein

Pages: 733-745

Published online: 25 Nov 2016

AbstractforEconomics of ramucirumab for metastatic colorectal cancer | Full Text | References | PDF (1 MB)

230 Views
2 CrossRef citations
0Altmetric

Review

Cost-effectiveness of professional pharmacy services in community pharmacy: a systematic review

A Malet-Larrea, V García-Cárdenas, L Sáez-Benito, SI Benrimoj, B Calvo & E Goyenechea

Pages: 747-758

Published online: 21 Nov 2016

AbstractforCost-effectiveness of professional pharmacy services in community pharmacy: a systematic review | Full Text | References | PDF (1.2 MB)

573 Views
24 CrossRef citations
0Altmetric

Review

Productivity losses associated with cardiovascular disease: a systematic review

Adam L Gordois, Peter P Toth, Ruben GW Quek, Emma M Proudfoot, Carly J Paoli & Shravanthi R Gandra

Pages: 759-769

Published online: 21 Nov 2016

AbstractforProductivity losses associated with cardiovascular disease: a systematic review | Full Text | References | PDF (853.3 KB)

809 Views
34 CrossRef citations
0Altmetric

Original Research

Article

A cost-effectiveness model for the use of a cannabis-derived oromucosal spray for the treatment of spasticity in multiple sclerosis

Adrien Gras & Julie Broughton

Pages: 771-779

Published online: 26 Feb 2016

AbstractforA cost-effectiveness model for the use of a cannabis-derived oromucosal spray for the treatment of spasticity in multiple sclerosis | Full Text | References | PDF (1.3 MB) | Supplemental

307 Views
8 CrossRef citations
0Altmetric

Article

Reimbursement of biosimilars in Poland: is there a link to health technology assessment?

Dominika Neumann & Anna Jabłecka

Pages: 781-792

Published online: 06 Feb 2016

AbstractforReimbursement of biosimilars in Poland: is there a link to health technology assessment? | Full Text | References | PDF (976.1 KB)

134 Views
3 CrossRef citations
0Altmetric

Article

Review and comparison of methodologies for indirect comparison of clinical trial results: an illustration with ranibizumab and aflibercept

Stephane A. Regnier, Jonathan Alsop, Jonathan Wright, Richard Nixon, Harry Staines & Franck Fajnkuchen

Pages: 793-801

Published online: 25 Mar 2016

AbstractforReview and comparison of methodologies for indirect comparison of clinical trial results: an illustration with ranibizumab and aflibercept | Full Text | References | PDF (772 KB) | Supplemental

468 Views
2 CrossRef citations
0Altmetric

Article

Variations in costs and use of provincially-funded testosterone replacement therapy across Canada: a population-based study

Mina Tadrous, Diana Martins, Kathy Lee, Sandra Knowles, Muhammad M. Mamdani, David N. Juurlink & Tara Gomes

Pages: 803-807

Published online: 06 Apr 2016

AbstractforVariations in costs and use of provincially-funded testosterone replacement therapy across Canada: a population-based study | Full Text | References | PDF (495.4 KB)

90 Views
0 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Cost-effectiveness analysis of atezolizumab plus bevacizumab compared with sorafenib as first-line treatment in advanced hepatocellular carcinoma in Singapore

Cheng Ean Chee et al.

Article | Published online: 22 May 2024

Quality-adjusted life years for HER2-positive, early-stage breast cancer using trastuzumab-containing regimens in the context of cost-effectiveness studies: a systematic review

Sudewi Mukaromah Khoirunnisa et al.

Review Article | Published online: 20 May 2024

Open Access

Economic evaluation of stereotactic radiotherapy and stereotactic radiosurgery technologies in the treatment of cancers: a systematic review

Aziz Rezapour et al.

Review Article | Published online: 20 May 2024

Unlocking the full potential of digital endpoints for decision making: a novel modular evidence concept enabling re-use and advancing collaboration

Lada Leyens et al.

Review Article | Published online: 15 May 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Review of Pharmacoeconomics & Outcomes Research (Vol.16, Iss.6, 2016)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?